Net Margin: quoinpharma.com (QNRX)

Symbol and logo of brand quoinpharma.com (QNRX)

Quoin Pharmaceuticals relies on a network of Western contract manufacturing organizations to eliminate logistical disruptions. Patent control over the treatment of rare dermatoses guarantees the company flexible pricing power. Anticipation of mid-phase trial results will serve as a key growth driver. The net profitability profile of sales demonstrates the profit-to-revenue dynamics, while the value of 0.00 shows the current magnitude of this financial indicator.

QNRX: Quoin Pharmaceuticals Ltd. Net Profit Rate 07/04/2022 - 11/20/2026

quoinpharma.com (QNRX) - metric breakdowns and financial figures

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Initial company analysis:Quoin Pharmaceuticals
Flagship merchandise of Quoin Pharmaceuticals

When constructing a long-term portfolio, fundamental screening requires an assessment of a business's ability to generate real cash flow. This indicator calculates the share of net profit within total revenue, determining the actual efficiency of each unit of sales. For Quoin Pharmaceuticals (QNRX), this metric depends critically on the success of a single drug and a narrow patient segment. Analyzing quarterly sales margins allows for the rapid tracking of the company's financial stability. While a positive trend confirms operational efficiency, peak values may signal an overvaluation of the asset.